The University of Southampton
University of Southampton Institutional Repository

Comparison of inflammatory responses in human lung, skin and nasal tissue

Comparison of inflammatory responses in human lung, skin and nasal tissue
Comparison of inflammatory responses in human lung, skin and nasal tissue
Inflammatory responses underpin many diseases in the skin, lung and upper airways.
This study aimed to develop an explant model to allow ex vivo study of responses in
these different tissues. Human skin (n= 120), lung (n=92) and nasal tissue (n=72) were
obtained from surgery with patients’ consent. Tissue was chopped into explants and
stimulated with inflammatory stimuli, then cytokine release measured.

Lung, skin and nasal tissue explants respond to stimulation with lipopolysaccharide
(LPS) and anti-IgE by releasing a similar panel of cytokines. Pro-inflammatory
cytokine TNF-α appears to be released first and may control release of other cytokines such as IL-1β, IL-6, IL-8 and IL-10. Whilst the kinetics of cytokine release from the different tissues are comparable, the magnitude is much higher from the lung; maximal TNF-α release from the lung is 79±13pg/mg tissue, from nasal tissue it reaches 39±11pg/mg tissue, but only 3.5±0.8pg/mg tissue is released from the skin. We have demonstrated similar numbers of macrophages in lung, skin and nasal tissue but there are significant differences in the numbers of mast cells, eosinophils and neutrophils. Furthermore we have shown that fewer cells migrate out of the skin during culture than the lung or nasal tissue, which may be pivotal in defining the level of responsiveness.

We have shown that heat-killed S.aureus can also induce cytokine release from lung, skin and nasal tissue explants, although this response may be mediated by the cell wall component peptidoglycan (PGN), as similar responses to non-pathogenic S.epidermidis were seen in the skin. Staphylococcal enterotoxins (SEs) A and B were also shown to induce cytokine release, although this occurred on a slower timescale and a distinct panel of cytokines were released. Of particular interest, SEB induced release of Th2 cytokines IL-5 and IL-13 from the lung, but only IL-5 from the nasal tissue and skin; this may have implications for the role of the bacteria in allergic priming in different tissues or could indicate prior exposure to S.aureus in some patients.

The corticosteroid dexamethasone downregulated LPS-, anti-IgE- and PGN-induced cytokine release from lung and nasal tissue explants, but failed to inhibit PGN-induced cytokine release from the skin, indicating the presence of distinct mechanisms in different tissues. Dexamethasone may increase expression of Toll-like receptor (TLR) 2 in keratinocytes, allowing PGN to continue to induce cytokine release, but this does not appear to occur in the other tissues. Immunosuppressive drugs cyclosporin A and methotrexate failed to downregulate TLR-mediated cytokine release in the skin. However, there appeared to be suppression of the T cell-mediated response, indicating that these drugs have distinct mechanisms of action to the corticosteroids.

In summary, we have demonstrated development of an ex vivo model to study inflammatory responses in human lung, skin and nasal tissue and we have demonstrated differences in responses to stimuli and anti-inflammatory drugs in the different tissues.
University of Southampton
Lowings, Kelly Marie
34e2728c-0998-41ab-8c00-2204762c3c6e
Lowings, Kelly Marie
34e2728c-0998-41ab-8c00-2204762c3c6e
Warner, Jane
8571b049-31bb-4a2a-a3c7-4184be20fe25
Wilson, Susan
21c6875d-6870-441b-ae7a-603562a646b8

Lowings, Kelly Marie (2010) Comparison of inflammatory responses in human lung, skin and nasal tissue. University of Southampton, Doctoral Thesis, 233pp.

Record type: Thesis (Doctoral)

Abstract

Inflammatory responses underpin many diseases in the skin, lung and upper airways.
This study aimed to develop an explant model to allow ex vivo study of responses in
these different tissues. Human skin (n= 120), lung (n=92) and nasal tissue (n=72) were
obtained from surgery with patients’ consent. Tissue was chopped into explants and
stimulated with inflammatory stimuli, then cytokine release measured.

Lung, skin and nasal tissue explants respond to stimulation with lipopolysaccharide
(LPS) and anti-IgE by releasing a similar panel of cytokines. Pro-inflammatory
cytokine TNF-α appears to be released first and may control release of other cytokines such as IL-1β, IL-6, IL-8 and IL-10. Whilst the kinetics of cytokine release from the different tissues are comparable, the magnitude is much higher from the lung; maximal TNF-α release from the lung is 79±13pg/mg tissue, from nasal tissue it reaches 39±11pg/mg tissue, but only 3.5±0.8pg/mg tissue is released from the skin. We have demonstrated similar numbers of macrophages in lung, skin and nasal tissue but there are significant differences in the numbers of mast cells, eosinophils and neutrophils. Furthermore we have shown that fewer cells migrate out of the skin during culture than the lung or nasal tissue, which may be pivotal in defining the level of responsiveness.

We have shown that heat-killed S.aureus can also induce cytokine release from lung, skin and nasal tissue explants, although this response may be mediated by the cell wall component peptidoglycan (PGN), as similar responses to non-pathogenic S.epidermidis were seen in the skin. Staphylococcal enterotoxins (SEs) A and B were also shown to induce cytokine release, although this occurred on a slower timescale and a distinct panel of cytokines were released. Of particular interest, SEB induced release of Th2 cytokines IL-5 and IL-13 from the lung, but only IL-5 from the nasal tissue and skin; this may have implications for the role of the bacteria in allergic priming in different tissues or could indicate prior exposure to S.aureus in some patients.

The corticosteroid dexamethasone downregulated LPS-, anti-IgE- and PGN-induced cytokine release from lung and nasal tissue explants, but failed to inhibit PGN-induced cytokine release from the skin, indicating the presence of distinct mechanisms in different tissues. Dexamethasone may increase expression of Toll-like receptor (TLR) 2 in keratinocytes, allowing PGN to continue to induce cytokine release, but this does not appear to occur in the other tissues. Immunosuppressive drugs cyclosporin A and methotrexate failed to downregulate TLR-mediated cytokine release in the skin. However, there appeared to be suppression of the T cell-mediated response, indicating that these drugs have distinct mechanisms of action to the corticosteroids.

In summary, we have demonstrated development of an ex vivo model to study inflammatory responses in human lung, skin and nasal tissue and we have demonstrated differences in responses to stimuli and anti-inflammatory drugs in the different tissues.

Text
Kelly Lowings e-thesis - Version of Record
Available under License University of Southampton Thesis Licence.
Download (102MB)

More information

Published date: February 2010

Identifiers

Local EPrints ID: 430369
URI: http://eprints.soton.ac.uk/id/eprint/430369
PURE UUID: ed77e0cb-d278-4f7f-aa8e-22e9a90a49d0
ORCID for Susan Wilson: ORCID iD orcid.org/0000-0003-1305-8271

Catalogue record

Date deposited: 26 Apr 2019 16:30
Last modified: 18 Feb 2021 16:40

Export record

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×